Qiankun Ni

1.1k total citations · 1 hit paper
17 papers, 935 citations indexed

About

Qiankun Ni is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Qiankun Ni has authored 17 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Qiankun Ni's work include Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (3 papers). Qiankun Ni is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (5 papers) and CAR-T cell therapy research (3 papers). Qiankun Ni collaborates with scholars based in China, New Zealand and Switzerland. Qiankun Ni's co-authors include Xing‐Jie Liang, Jinghong Li, Yuxuan Zhang, Chunrong Yang, Jinjin Wang, Yujie Li, Yuchen Yang, Jinchao Zhang, Guangchao Qing and Ningqiang Gong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Qiankun Ni

17 papers receiving 927 citations

Hit Papers

Radiotherapy-Triggered Proteolysis Targeting Chimera Prod... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiankun Ni China 14 435 416 265 194 169 17 935
Adam Yuh Lin United States 15 377 0.9× 454 1.1× 320 1.2× 238 1.2× 148 0.9× 39 988
Luan N. Nguyen Canada 15 445 1.0× 351 0.8× 165 0.6× 213 1.1× 233 1.4× 26 996
Stefania Biffi Italy 23 518 1.2× 315 0.8× 222 0.8× 271 1.4× 105 0.6× 55 1.3k
Jinxing Xia China 14 415 1.0× 500 1.2× 315 1.2× 322 1.7× 290 1.7× 28 1.1k
Shabnum Patel United States 14 455 1.0× 227 0.5× 249 0.9× 251 1.3× 273 1.6× 27 1.1k
Vladimir Mulens‐Arias Spain 14 204 0.5× 278 0.7× 239 0.9× 255 1.3× 92 0.5× 24 753
Dimitrios C. Arhontoulis United States 6 227 0.5× 320 0.8× 218 0.8× 259 1.3× 305 1.8× 9 777
Yesi Shi China 14 383 0.9× 539 1.3× 129 0.5× 217 1.1× 61 0.4× 23 958
Jiwoong Choi South Korea 14 281 0.6× 497 1.2× 215 0.8× 259 1.3× 226 1.3× 24 844
John‐Michael Williford United States 10 473 1.1× 347 0.8× 342 1.3× 312 1.6× 302 1.8× 11 1.2k

Countries citing papers authored by Qiankun Ni

Since Specialization
Citations

This map shows the geographic impact of Qiankun Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiankun Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiankun Ni more than expected).

Fields of papers citing papers by Qiankun Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiankun Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiankun Ni. The network helps show where Qiankun Ni may publish in the future.

Co-authorship network of co-authors of Qiankun Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Qiankun Ni. A scholar is included among the top collaborators of Qiankun Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiankun Ni. Qiankun Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Yuxuan, Jinjin Wang, Guangchao Qing, et al.. (2025). Controlling T cell–tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy. Proceedings of the National Academy of Sciences. 122(28). e2500589122–e2500589122. 2 indexed citations
2.
Ni, Qiankun, Ningqiang Gong, Bozhang Xia, et al.. (2024). Delivery Systems Developed for Treatment Combinations to Improve Adoptive Cell Therapy. Advanced Materials. 36(40). e2407525–e2407525. 3 indexed citations
3.
Chen, Junge, Gang Zhang, Bozhang Xia, et al.. (2023). Immune cell-derived exosomes as promising tools for cancer therapy. Journal of Controlled Release. 364. 508–528. 22 indexed citations
4.
Li, Xianlei, Ningqiang Gong, Falin Tian, et al.. (2023). Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel. Nature Biomedical Engineering. 7(9). 1129–1141. 47 indexed citations
5.
Yang, Chunrong, Yujie Li, Yuchen Yang, et al.. (2023). Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma. Angewandte Chemie. 135(49). 1 indexed citations
6.
Yang, Chunrong, Yujie Li, Yuchen Yang, et al.. (2023). Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma. Angewandte Chemie International Edition. 62(49). e202312603–e202312603. 13 indexed citations
7.
Ni, Qiankun, Yufei Wang, Yujie Li, et al.. (2022). Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy. Journal of Controlled Release. 342. 210–227. 22 indexed citations
8.
Yang, Chunrong, Yuchen Yang, Yujie Li, Qiankun Ni, & Jinghong Li. (2022). Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors. Journal of the American Chemical Society. 145(1). 385–391. 129 indexed citations breakdown →
9.
Wu, Long, Qiankun Ni, Peter Timashev, et al.. (2022). Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System. Advanced Science. 9(17). e2105376–e2105376. 67 indexed citations
10.
Zhong, Yixin, Man Ye, Qiankun Ni, et al.. (2022). A Fibrin Site‐Specific Nanoprobe for Imaging Fibrin‐Rich Thrombi and Preventing Thrombus Formation in Venous Vessels. Advanced Materials. 34(16). e2109955–e2109955. 26 indexed citations
11.
Wang, Yongchao, Ningqiang Gong, Chi Ma, et al.. (2021). An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination. Nature Communications. 12(1). 4964–4964. 68 indexed citations
12.
Gong, Ningqiang, Yuxuan Zhang, Xucong Teng, et al.. (2020). Proton-driven transformable nanovaccine for cancer immunotherapy. Nature Nanotechnology. 15(12). 1053–1064. 255 indexed citations
13.
Feng, Zujian, Qinghua Li, Weiwei Wang, et al.. (2020). Superhydrophilic fluorinated polymer and nanogel for high-performance 19F magnetic resonance imaging. Biomaterials. 256. 120184–120184. 44 indexed citations
14.
Wang, Jinjin, Qiankun Ni, Yufei Wang, et al.. (2020). Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration. Journal of Controlled Release. 331. 282–295. 81 indexed citations
15.
Han, Yu, Shutao Gao, Yinghua Zhang, et al.. (2020). Metal-Based Nanocatalyst for Combined Cancer Therapeutics. Bioconjugate Chemistry. 31(5). 1247–1258. 49 indexed citations
16.
Xu, Yang, Jingqing Mu, Zunkai Xu, et al.. (2020). Modular Acid-Activatable Acetone-Based Ketal-Linked Nanomedicine by Dexamethasone Prodrugs for Enhanced Anti-Rheumatoid Arthritis with Low Side Effects. Nano Letters. 20(4). 2558–2568. 79 indexed citations
17.
Wang, Kunhua, Jun‐Nan Yang, Qiankun Ni, Hong‐Bin Yao, & Shu‐Hong Yu. (2017). Metal Halide Perovskite Supercrystals: Gold–Bromide Complex Triggered Assembly of CsPbBr3 Nanocubes. Langmuir. 34(2). 595–602. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026